Internal Medicine · Midland, TX
NPI
1760860720
Since 2015
Specialty
Internal Medicine
Code 207R00000X
Group practices
7
Medicare group memberships
Hospitals
3
Hospital affiliations
4507 Santa Rosa Dr
Midland, TX, 79707
Phone (432) 683-8516
Groups this clinician bills Medicare through
Medicare paid, 2024
$327K
13,499 services
Medicare patients, 2024
825
Average age 76
Drug cost, 2024
$1.5M
27,467 prescriptions
Company payments, 2025
$654
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey H Atkins was code J1010 (injection, methylprednisolone acetate, 1 mg), 7,481 times for 67 patients. In total Jeffrey H Atkins billed 13,499 services in 42 codes, and Medicare paid $327K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 7,481 | 67 | $0.10 | $754 |
| 99232 Hospital E&M - Subsequent | Facility | 3,215 | 321 | $59.12 | $190K |
| 99214 Office E&M - Established | Office | 621 | 323 | $82.00 | $51K |
| 96372 Injection Administration | Office | 446 | 118 | $9.57 | $4,268 |
| 99222 Hospital E&M - Initial | Facility | 303 | 245 | $97.37 | $30K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 216 | 47 | $0.83 | $180 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 148 | 21 | $0.34 | $50.67 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 118 | 24 | $44.89 | $5,297 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 102 | 102 | $130.52 | $13K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 99 | 99 | $18.91 | $1,872 |
| 99490 Chronic, Principal, and Transitional Care Management | Facility | 98 | 26 | $37.84 | $3,709 |
| 99213 Office E&M - Established | Office | 83 | 77 | $43.31 | $3,595 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 62 | 36 | $42.95 | $2,663 |
| G0008 Administration of influenza virus vaccine | Office | 57 | 57 | $19.60 | $1,117 |
| 90661 Vaccine Product | Office | 56 | 56 | $28.88 | $1,617 |
By year: 2022 $390K for 40,334 services; 2023 $424K for 29,098 services; 2024 $327K for 13,499 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87804 Immunoassay | 25 | 13 | $16.22 | $406 |
| 87811 Immunoassay | 22 | 20 | $24.50 | $539 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey H Atkins prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,341 prescriptions and refills. In total Jeffrey H Atkins wrote 27,467 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,341 | 2,029 | 198 | $10K |
| Levothyroxine Sodium Generic | 1,144 | 1,871 | 205 | $9,449 |
| Furosemide Generic | 1,096 | 1,228 | 140 | $4,253 |
| Gabapentin Generic | 1,064 | 1,229 | 116 | $9,424 |
| Pantoprazole Sodium Generic | 1,013 | 1,320 | 147 | $8,074 |
| Amlodipine Besylate Generic | 919 | 1,191 | 128 | $4,544 |
| Lisinopril Generic | 892 | 1,355 | 127 | $5,177 |
| Donepezil Hcl Generic | 656 | 770 | 73 | $4,900 |
| Tamsulosin Hcl Generic | 648 | 896 | 93 | $7,423 |
| Klor-Con M20 Potassium Chloride | 551 | 567 | 40 | $4,298 |
| Metoprolol Tartrate Generic | 541 | 664 | 63 | $2,243 |
| Eliquis Apixaban | 479 | 559 | 81 | $246K |
| Losartan Potassium Generic | 469 | 738 | 89 | $3,648 |
| Carvedilol Generic | 435 | 535 | 56 | $2,030 |
| Escitalopram Oxalate Generic | 432 | 558 | 57 | $3,287 |
Brand drugs: 2,519 claims; generic drugs: 24,819 claims; opioid claims: 541.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey H Atkins $654 ($654 in general payments such as food, travel and fees) from 13 companies. The largest payer was Sumitomo Pharma America, Inc. with $171.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 7 | $171 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $68.54 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $65.1 |
| Paratek Pharmaceuticals, Inc. | 3 | $53.76 |
| Novo Nordisk Inc NVO | 2 | $37.8 |
| Lilly USA, LLC LLY | 2 | $33.84 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $31.81 |
| Inspire Medical Systems, Inc. INSP | 1 | $20.41 |
| Esperion Therapeutics, Inc. ESPR | 1 | $17.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.